2-1842071-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000471668.1(MYT1L):​c.-1211A>G variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.492 in 152,172 control chromosomes in the GnomAD database, including 20,964 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.49 ( 20958 hom., cov: 33)
Exomes 𝑓: 0.52 ( 6 hom. )

Consequence

MYT1L
ENST00000471668.1 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.195

Publications

5 publications found
Variant links:
Genes affected
MYT1L (HGNC:7623): (myelin transcription factor 1 like) This gene encodes a member of the zinc finger superfamily of transcription factors whose expression, thus far, has been found only in neuronal tissues. The encoded protein belongs to a novel class of cystein-cystein-histidine-cystein zinc finger proteins that function in the developing mammalian central nervous system. Forced expression of this gene in combination with the basic helix-loop-helix transcription factor NeuroD1 and the transcription factors POU class 3 homeobox 2 and achaete-scute family basic helix-loop-helix transcription factor 1 can convert fetal and postnatal human fibroblasts into induced neuronal cells, which are able to generate action potentials. Mutations in this gene have been associated with an autosomal dominant form of cognitive disability and with autism spectrum disorder. Alternative splicing results in multiple variants. [provided by RefSeq, Jul 2017]
MYT1L Gene-Disease associations (from GenCC):
  • intellectual disability, autosomal dominant 39
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • syndromic intellectual disability
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.767 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYT1LNM_001303052.2 linkc.2775-1228A>G intron_variant Intron 19 of 24 ENST00000647738.2 NP_001289981.1 Q9UL68-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYT1LENST00000647738.2 linkc.2775-1228A>G intron_variant Intron 19 of 24 NM_001303052.2 ENSP00000497479.2 Q9UL68-1

Frequencies

GnomAD3 genomes
AF:
0.492
AC:
74770
AN:
152004
Hom.:
20907
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.773
Gnomad AMI
AF:
0.377
Gnomad AMR
AF:
0.362
Gnomad ASJ
AF:
0.384
Gnomad EAS
AF:
0.667
Gnomad SAS
AF:
0.379
Gnomad FIN
AF:
0.405
Gnomad MID
AF:
0.358
Gnomad NFE
AF:
0.367
Gnomad OTH
AF:
0.459
GnomAD4 exome
AF:
0.520
AC:
26
AN:
50
Hom.:
6
Cov.:
0
AF XY:
0.447
AC XY:
17
AN XY:
38
show subpopulations
African (AFR)
AF:
0.500
AC:
1
AN:
2
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
1.00
AC:
2
AN:
2
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.500
AC:
1
AN:
2
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.500
AC:
18
AN:
36
Other (OTH)
AF:
0.500
AC:
4
AN:
8
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.546
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.492
AC:
74870
AN:
152122
Hom.:
20958
Cov.:
33
AF XY:
0.490
AC XY:
36405
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.774
AC:
32134
AN:
41538
American (AMR)
AF:
0.362
AC:
5529
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.384
AC:
1331
AN:
3466
East Asian (EAS)
AF:
0.666
AC:
3433
AN:
5152
South Asian (SAS)
AF:
0.379
AC:
1821
AN:
4808
European-Finnish (FIN)
AF:
0.405
AC:
4282
AN:
10576
Middle Eastern (MID)
AF:
0.344
AC:
101
AN:
294
European-Non Finnish (NFE)
AF:
0.367
AC:
24928
AN:
67978
Other (OTH)
AF:
0.459
AC:
967
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1784
3568
5353
7137
8921
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
646
1292
1938
2584
3230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.406
Hom.:
7379
Bravo
AF:
0.505
Asia WGS
AF:
0.509
AC:
1767
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.69
DANN
Benign
0.38
PhyloP100
-0.20
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4073401; hg19: chr2-1845843; API